465PA phase I open label dose escalation trial evaluating VT1021 in patients with advanced solid tumours
Harb, W, Patnaik, A, Mahalingam, D, Liu, J, Wen, P Y, Shapiro, G I, Bullock, A J, Juric, D, Zheng, L, Moore, K, Patel, M, Guttendorf, R, Wang, S, Kerstein, K, Berk, G, Cieslewicz, M J, Watnick, JVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz244.027
Date:
October, 2019
File:
PDF, 77 KB
2019